Assure Tech Hangzhou Co Ltd (688075) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, Assure Tech Hangzhou Co Ltd (688075) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.25 Million ≈ $-329.31K USD) by net assets (CN¥5.16 Billion ≈ $754.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688075 equity financing ratio to measure how much of total assets are equity-financed.

Assure Tech Hangzhou Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Assure Tech Hangzhou Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Assure Tech Hangzhou Co Ltd (688075) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Assure Tech Hangzhou Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Assure Tech Hangzhou Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Pagerduty Inc
NYSE:PD
0.094x
Cimentas Izmir Cimento Fabrikasi TAS
IS:CMENT
0.007x
Beijing Bewinner Communications Co Ltd
SHE:002148
-0.005x
Viyash Scientific Limited
NSE:SEQUENT
0.051x
Yaari Digital Integrated Services Limited
NSE:YAARI
0.000x
Brandywine Realty Trust
NYSE:BDN
0.014x
SECHE ENVIRO.UNSP.ADR 1/5
F:SCB0
N/A
Eastern Polymer Group Public Company Limited
BK:EPG
0.054x

Annual Cash Flow Conversion Efficiency for Assure Tech Hangzhou Co Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Assure Tech Hangzhou Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Assure Tech Hangzhou Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.16 Billion
≈ $755.16 Million
CN¥-9.41 Million
≈ $-1.38 Million
-0.002x -112.62%
2024-12-31 CN¥5.20 Billion
≈ $760.89 Million
CN¥75.09 Million
≈ $10.99 Million
0.014x +111.83%
2023-12-31 CN¥5.11 Billion
≈ $747.13 Million
CN¥-623.08 Million
≈ $-91.18 Million
-0.122x -117.67%
2022-12-31 CN¥5.42 Billion
≈ $792.94 Million
CN¥3.74 Billion
≈ $547.76 Million
0.691x +166.38%
2021-12-31 CN¥2.61 Billion
≈ $381.41 Million
CN¥675.94 Million
≈ $98.91 Million
0.259x -65.05%
2020-12-31 CN¥811.69 Million
≈ $118.78 Million
CN¥602.20 Million
≈ $88.12 Million
0.742x +519.59%
2019-12-31 CN¥162.36 Million
≈ $23.76 Million
CN¥19.44 Million
≈ $2.84 Million
0.120x +0.89%
2018-12-31 CN¥102.68 Million
≈ $15.02 Million
CN¥12.19 Million
≈ $1.78 Million
0.119x -54.33%
2017-12-31 CN¥63.54 Million
≈ $9.30 Million
CN¥16.51 Million
≈ $2.42 Million
0.260x --

About Assure Tech Hangzhou Co Ltd

SHG:688075 China Biotechnology
Market Cap
$528.50 Million
CN¥3.61 Billion CNY
Market Cap Rank
#11912 Global
#3409 in China
Share Price
CN¥28.42
Change (1 day)
-0.07%
52-Week Range
CN¥26.90 - CN¥44.42
All Time High
CN¥125.68
About

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veteri… Read more